【24h】

Clearance in Drug Design

机译:药物设计清关

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Due to its implications for both dose level and frequency, clearance rate is one of the most important pharmacokinetic parameters to consider in the design of drug candidates. Clearance can be classified into three general categories, namely, metabolic transformation, renal excretion, and hepatobiliary excretion. Within each category, there are a host of biochemical and physiological mechanisms that ultimately determine the clearance rate. Physiochemical properties are often indicative of the rate-determining mechanism, with lipophilic molecules tending toward metabolism and hydrophilic, polar molecules tending toward passive or active excretion. Optimization of clearance requires recognition of the major clearance mechanisms and use of the most relevant in vitro and in vivo tools to develop structure-clearance relationships. The reliability of methods to detect and predict human clearance varies across mechanisms. While methods for metabolic and passive renal clearance have proven reasonably robust, there is a clear need for better tools to support the optimization of transporter-mediated clearance.
机译:由于其对剂量水平和频率的影响,清关率是在候选药物设计中考虑的最重要的药代动力学参数之一。清关可以分为三个一般类别,即代谢转化,肾脏排泄和肝胆排泄。在每个类别中,有许多生物化学和生理机制最终决定了许可率。物理化学性质通常表示速率确定机制,倾向于代谢和亲水性,极性分子倾向于被动或活性排泄。优化清除需要识别主要的间隙机制和使用中最相关的体外和体内工具,以开发结构间隙关系。检测和预测人类间隙的方法的可靠性在机制上变化。虽然代谢和被动肾脏间隙的方法已被证明具有合理的稳健性,但明确需要更好的工具来支持转运介导的间隙的优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号